Adults with allo-HSCT (n = 296) | Pediatrics with allo-HSCT (n = 21) | Adults at risk (n = 250) | Pediatrics at risk (n = 19) | |
---|---|---|---|---|
no GvHD | 107 (36.1%) | 15 (71.4%) | 70 (28.0%) | 13 (68.4%) |
aGvHD | 127 (42.9%) | 6 (28.6%) | 118 (47.2%) | 6 (31.6%) |
laGvHD | 28 (9.5%) | 1 (4.8%) | 28 (11.2%) | 1 (5.3%) |
cGvHD | 109 (37.2%) | 2 (9.5%) | 109 (43.6%) | 2 (10.5%) |
mild | 56 (51.4%) | 0 (0.0%) | 56 (51.4%) | 0 (0.0%) |
moderate | 43 (38.5%) | 1 (50.0%) | 43 (38.5%) | 1 (50.0%) |
severe | 10 (8.3%) | 1 (50.0%) | 10 (8.3%) | 1 (50.0%) |